Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dimerix Limited (AU:DXB)
ASX:DXB
Dimerix Limited (DXB) Share Price & Analysis
5 Followers
DXB Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.37
Previous CloseAU$0.32
Volume1.68M
Average Volume (3M)4.29M
Market Cap
AU$175.87M
Enterprise ValueAU$166.32M
Total Cash (Recent Filing)AU$9.63M
Total Debt (Recent Filing)AU$73.10K
Price to Earnings (P/E)-11.1
Beta0.19
Next Earnings
Aug 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares OutstandingN/A
10 Day Avg. Volume548,720
30 Day Avg. Volume4,289,537
Standard Deviation3.39
R-Squared0.00644
Alpha0.51
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Dimerix Limited News
PremiumCompany Announcements
Dimerix Limited Expands Securities Quotation
PremiumCompany Announcements
Dimerix’s Drug Shows Promise in Interim Phase 3 Trial
PremiumCompany Announcements
Dimerix Limited Announces Option Expiries
PremiumCompany Announcements
Dimerix Limited Expands Market PresenceOptions Prices
Currently, No data available
---
Ownership Overview
7.07% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
92.93% Public Companies and
Individual Investors
DXB FAQ
What was Dimerix Limited’s price range in the past 12 months?
Dimerix Limited lowest share price was AU$0.05 and its highest was AU$0.37 in the past 12 months.
What is Dimerix Limited’s market cap?
Currently, no data Available
When is Dimerix Limited’s upcoming earnings report date?
Dimerix Limited’s upcoming earnings report date is Aug 27, 2024 which is in 118 days.
How were Dimerix Limited’s earnings last quarter?
Dimerix Limited released its earnings results on Feb 25, 2024. The company reported -AU$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.016.
Is Dimerix Limited overvalued?
According to Wall Street analysts Dimerix Limited’s price is currently Overvalued.
Does Dimerix Limited pay dividends?
Dimerix Limited does not currently pay dividends.
What is Dimerix Limited’s EPS estimate?
Dimerix Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dimerix Limited have?
Dimerix Limited has 549,602,400 shares outstanding.
What happened to Dimerix Limited’s price movement after its last earnings report?
Dimerix Limited reported an EPS of -AU$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Dimerix Limited?
Currently, no hedge funds are holding shares in AU:DXB
---
Dimerix Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DXB Sentiment 96%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$10.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
240.42%
12-Months-Change
Fundamentals
Return on Equity
-330.96%
Trailing 12-Months
Asset Growth
137.51%
Trailing 12-Months
Company Description
Dimerix Limited
Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
---
Technical Analysis
---